Stephen A Sherwin

Director, Neurocrine Biosciences

Bought, 12 months

$0.0M

Sold, 12 months

$4.1M

Companies

Latest trade

Jun 5, 2026

Companies

Neurocrine BiosciencesDirector −$4.1M

Trades

NBIX Sold 25,000 shares at $165.32 · planned $4.1M Jun 5

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.